Matthew Roden

Insider Reports History

Entity
Individual
Location
450 Kendall Street, Cambridge, MA
Signature
/s/ Adi Osovsky, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Roden:

Stock Role Class Num Shares Value Price $ Report Date Ownership
iTeos Therapeutics, Inc. Director Stock Option (Right to Buy) 17.5K Jun 9, 2022 Direct

Insider Reports Filed by Matthew Roden

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ITOS iTeos Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
ITOS iTeos Therapeutics, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director